0

IL-16 Regulation of Human Mast cells/basophils and Their Susceptibility to HIV-1

Jian Cheng Qi, Richard L Stevens, Robert Wadley, Andrew Collins, Margaret Cooley, Hassan M Naif, Najla Nasr, Anthony Cunningham, Gregory Katsoulotos, Yewlan Wanigasek, Basil Roufogalis, Steven A Krilis

J Immunol. 2002 Apr 15;168(8):4127-34.

PMID: 11937573

Abstract:

AIDS patients often contain HIV-1-infected mast cells (MCs)/basophils in their peripheral blood, and in vivo-differentiated MCs/basophils have been isolated from the blood of asthma patients that are HIV-1 susceptible ex vivo due to their surface expression of CD4 and varied chemokine receptors. Because IL-16 is a ligand for CD4 and/or an undefined CD4-associated protein, the ability of this multifunctional cytokine to regulate the development of human MCs/basophils from nongranulated progenitors residing in cord or peripheral blood was evaluated. After 3 wk of culture in the presence of c-kit ligand, IL-16 induced the progenitors residing in the blood of normal individuals to increase their expression of chymase and tryptase about 20-fold. As assessed immunohistochemically, >80% of these tryptase(+) and/or chymase(+) cells expressed CD4. The resulting cells responded to IL-16 in an in vitro chemotaxis assay, and this biologic response could be blocked by anti-IL-16 and anti-CD4 Abs as well as by a competitive peptide inhibitor corresponding to a sequence in the C-terminal domain of IL-16. The additional finding that IL-16 induces calcium mobilization in the HMC-1 cell line indicates that IL-16 acts directly on MCs and their committed progenitors. IL-16-treated MCs/basophils also are less susceptible to infection by an M/R5-tropic strain of HIV-1. Thus, IL-16 regulates MCs/basophils at a number of levels, including their vulnerability to retroviral infection.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
IAR4248778 IL-16 human IL-16 human Price
qrcode